Contraceptives Market

• 6.1. Drugs
  • 6.1.1. Oral Contraceptives
    • 6.1.1.1. Combined Contraceptives
    • 6.1.1.2. Mini-pills
  • 6.1.2. Injectable
  • 6.1.3. Topical Patch
• 6.2. Injectable
  • 6.2.1. Male Devices
  • 6.2.2. Female Devices
    • 6.2.2.1. Female Condoms
    • 6.2.2.2. Diaphragms
    • 6.2.2.3. Sponges
    • 6.2.2.4. Vaginal Rings
    • 6.2.2.5. Intrauterine Devices
    • 6.2.2.6. Sub-dermal Contraceptives Implants
    • 6.2.2.7. Non-Surgical Permanent Contraception Devices

• 7.1. Hospital Pharmacy
  • 7.1.1. Public
  • 7.1.2. Private
• 7.2. Independent Pharmacy
• 7.3. Online Platform
• 7.4. Clinics
• 7.5. Others

• 8.1. North America
• 8.2. Europe
• 8.3. Asia Pacific
• 8.4. Latin America
• 8.5. Middle East & Africa

• 14.1. Merck & Co., Inc.
• 14.2. Cipla Inc.
• 14.3. Allergan plc
• 14.4. Bayer AG
• 14.5. HLL Lifecare Limited
• 14.6. Mankind Pharma
• 14.7. Pfizer, Inc.
• 14.8. Teva Pharmaceutical Industries Ltd
• 14.9. Mithra Pharmaceuticals
• 14.10. Janssen Pharmaceutical Company
• 14.11. Reckitt Benckiser Group plc

Table 01: Global Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 02: Global Market Size (US$ Mn) Forecast, by Drugs, 2023 to 2033

Table 03: Global Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023 to 2033

Table 04: Global Market Size (US$ Mn) Forecast, by Devices, 2023 to 2033

Table 05: Global Market Size (US$ Mn) Forecast, by Female Devices, 2023 to 2033

Table 06: Global Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 07: Global Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023 to 2033

Table 08: Global Market Size (US$ Mn) Forecast, by Region, 2023 to 2033

Table 09: North America Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 10: North America Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 11: North America Market Size (US$ Mn) Forecast, by Drugs, 2023 to 2033

Table 12: North America Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023 to 2033

Table 13: North America Market Size (US$ Mn) Forecast, by Devices, 2023 to 2033

Table 14: North America Market Size (US$ Mn) Forecast, by Female Devices, 2023 to 2033

Table 15: North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 16: North America Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023 to 2033

Table 17: Europe Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 18: Europe Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 19: Europe Market Size (US$ Mn) Forecast, by Drugs, 2023 to 2033

Table 20: Europe Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023 to 2033

Table 21: Europe Market Size (US$ Mn) Forecast, by Devices, 2023 to 2033

Table 22: Europe Market Size (US$ Mn) Forecast, by Female Devices, 2023 to 2033

Table 23: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 24: Europe Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023 to 2033

Table 25: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 26: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 27: Asia Pacific Market Size (US$ Mn) Forecast, by Drugs, 2023 to 2033

Table 28: Asia Pacific Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023 to 2033

Table 29: Asia Pacific Market Size (US$ Mn) Forecast, by Devices, 2023 to 2033

Table 30: Asia Pacific Market Size (US$ Mn) Forecast, by Female Devices, 2023 to 2033

Table 31: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 32: Asia Pacific Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023 to 2033

Table 33: Latin America Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 34: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 35: Latin America Market Size (US$ Mn) Forecast, by Drugs, 2023 to 2033

Table 36: Latin America Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023 to 2033

Table 37: Latin America Market Size (US$ Mn) Forecast, by Devices, 2023 to 2033

Table 38: Latin America Market Size (US$ Mn) Forecast, by Female Devices, 2023 to 2033

Table 39: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 40: Latin America Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023 to 2033

Table 41: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2023 to 2033

Table 42: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 43: Middle East & Africa Market Size (US$ Mn) Forecast, by Drugs, 2023 to 2033

Table 44: Middle East & Africa Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023 to 2033

Table 45: Middle East & Africa Market Size (US$ Mn) Forecast, by Devices, 2023 to 2033

Table 46: Middle East & Africa Market Size (US$ Mn) Forecast, by Female Devices, 2023 to 2033

Table 47: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2023 to 2033

Table 48: Middle East & Africa Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023 to 2033

Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2023 to 2033

Figure 02: Global Market Value Share, by Product (2022)

Figure 03: Global Market Value Share, by Distribution Channel (2022)

Figure 04: Global Market Value Share, by Region (2022)

Figure 05: Global Market Value Share, by Product Type, 2023 and 2033

Figure 06: Global Market Attractiveness, by Product Type, 2023 to 2033

Figure 07: Global Market Value Share, by Drugs, 2023 and 2033

Figure 08: Global Market Attractiveness, by Drugs, 2023 to 2033

Figure 09: Global Market Value Share, by Oral Contraceptives, 2023 and 2033

Figure 10: Global Market Attractiveness, by Oral Contraceptives, 2023 to 2033

Figure 11: Global Market Value Share, by Devices, 2023 and 2033

Figure 12: Global Market Attractiveness, by Devices, 2023 to 2033

Figure 13: Global Market Value Share, by Female Devices, 2023 and 2033

Figure 14: Global Market Attractiveness, by Female Devices, 2023 to 2033

Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Drugs, 2023 to 2033

Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Devices, 2023 to 2033

Figure 17: Global Market Value Share, by Distribution Channel, 2023 and 2033

Figure 18: Global Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2023 to 2033

Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2023 to 2033

Figure 21: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2023 to 2033

Figure 22: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2023 to 2033

Figure 23: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2023 to 2033

Figure 24: Global Market Value Share, by Region, 2023 and 2033

Figure 25: Global Market Attractiveness, by Region, 2023 to 2033

Figure 26: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023 to 2033

Figure 27: North America Market Attractiveness, by Country 2023 to 2033

Figure 28: North America Market Value Share, by Country, 2023 and 2033

Figure 29: North America Market Value Share, by Product Type, 2023 and 2033

Figure 30: North America Market Attractiveness, by Product Type, 2023 to 2033

Figure 31: North America Market Value Share, by Distribution Channel, 2023 and 2033

Figure 32: North America Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 33: Europe Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023 to 2033

Figure 34: Europe Market Attractiveness, by Country, 2023 to 2033

Figure 35: Europe Market Value Share, by Country, 2023 and 2033

Figure 36: Europe Market Value Share, by Product, 2023 and 2033

Figure 37: Europe Market Attractiveness, by Product, 2023 to 2033

Figure 38: Europe Market Value Share, by Distribution Channel, 2023 and 2033

Figure 39: Europe Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 40: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023 to 2033

Figure 41: Asia Pacific Market Attractiveness, by Country 2023 to 2033

Figure 42: Asia Pacific Market Value Share, by Country, 2023 and 2033

Figure 43: Asia Pacific Market Value Share, by Product Type, 2023 and 2033

Figure 44: Asia Pacific Market Attractiveness, by Product Type, 2023 to 2033

Figure 45: Asia Pacific Market Value Share, by Distribution Channel, 2023 and 2033

Figure 46: Asia Pacific Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 47: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023 to 2033

Figure 48: Latin America Market Attractiveness, by Country 2023 to 2033

Figure 49: Latin America Market Value Share, by Country, 2023 and 2033

Figure 50: Latin America Market Value Share, by Product Type, 2023 and 2033

Figure 51: Latin America Market Attractiveness, by Product Type, 2023 to 2033

Figure 52: Latin America Market Value Share, by Distribution Channel, 2023 and 2033

Figure 53: Latin America Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 54: Middle East & Africa Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023 to 2033

Figure 55: Middle East & Africa Market Attractiveness, by Country 2023 to 2033

Figure 56: Middle East & Africa Market Value Share, by Country, 2023 and 2033

Figure 57: Middle East & Africa Market Value Share, by Product Type, 2023 and 2033

Figure 58: Middle East & Africa Market Attractiveness, by Product Type, 2023 to 2033

Figure 59: Middle East & Africa Market Value Share, by Distribution Channel, 2023 and 2033

Figure 60: Middle East & Africa Market Attractiveness, by Distribution Channel, 2023 to 2033

Figure 61: Global Drugs Market Share, by Company, 2022

Figure 62: Global Devices Market Share, by Company, 2022